Hadieh Eslampanah, Director of International Development and Communications Department at MAHAK, shared on LinkedIn:
“It was an honor and a privilege to be present at a remarkable milestone in pediatric cellular medicine; celebration of 1,000 stem cell transplants at the Children’s Medical Center, alongside distinguished experts and pioneers in the field of stem cell transplantation and cellular therapies, Tehran 2026.
Milestones like this represent far more than numbers – they reflect years of scientific dedication, clinical excellence, multidisciplinary collaboration, and countless moments of hope for children and their families.
Our heartfelt congratulations to Prof. Amir Ali Hamidieh and his team for this significant achievement and for their continued commitment to advancing pediatric medicine and transplantation.
As someone working at the intersection of health, medical biotechnology, communications, and international development, I believe the opportunities at national level to advance innovative cellular therapies, including the evolving potential of CAR T-cell–based approaches, as well as gene therapy and targeted cancer therapeutics.
These advances have the potential to contribute to a safer and more promising future for young patients across Iran.
At our twinning transplant program of MAHAK highly specialized pediatric cancer hospital and research center; we looks forward to exploring meaningful opportunities for collaboration in stem cell transplantation, cellular therapies, and translational healthcare innovation at national and international scale – connecting scientific excellence with meaningful impact where it matters most.
Here’s to continued scientific collaboration, innovation, and a brighter future for every child.”
You can also read:
CancerWorld September Issue Explores What Comes After Childhood Cancer Survival
